WINDTREE THERAPEUTICS INC /DE/ Increase (Decrease) in Prepaid Interest
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Increase (Decrease) in Prepaid Interest of -$912.00 thousand for the 12-month period ending 2017-12-31, per its 10-K/A filed 2019-04-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidInterest · last filed 2019-04-23
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for the quarter ending 2017-12-31 was -$94.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for the quarter ending 2017-09-30 was -$275.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for the quarter ending 2017-06-30 was -$273.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for the quarter ending 2017-03-31 was -$270.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for fiscal 2017 was -$912.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for fiscal 2016 was -$1.71M.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for fiscal 2015 was -$971.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in prepaid interest for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Prepaid Interest 1 month | Increase (Decrease) in Prepaid Interest 3 month | Increase (Decrease) in Prepaid Interest 6 month | Increase (Decrease) in Prepaid Interest 9 month | Increase (Decrease) in Prepaid Interest 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | -$94.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | -$369.00K derived: sum of 2 quarters · filed 2019-04-23 | -$642.00K derived: sum of 3 quarters · filed 2019-04-23 | -$912.00K 10-K/A · filed 2019-04-23 | |
| 2017-09-30 | -$275.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$548.00K derived: sum of 2 quarters · filed 2018-11-14 | -$818.00K 10-Q · filed 2018-11-14 | -$1.09M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$543.00K 10-Q · filed 2018-08-14 | -$817.00K derived: sum of 3 quarters · filed 2018-08-14 | -$1.16M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$270.00K 10-Q · filed 2018-05-21 | -$544.00K derived: sum of 2 quarters · filed 2018-05-21 | -$891.00K derived: sum of 3 quarters · filed 2018-05-21 | -$1.44M derived: sum of 4 quarters · filed 2018-05-21 | |
| 2016-12-31 | -$1.71M 10-K · filed 2017-03-31 | -$274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | -$621.00K derived: sum of 2 quarters · filed 2018-04-17 | -$1.17M derived: sum of 3 quarters · filed 2018-04-17 | -$1.71M 10-K · filed 2018-04-17 |
| 2016-09-30 | -$347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$891.00K derived: sum of 2 quarters · filed 2017-11-14 | -$1.44M 10-Q · filed 2017-11-14 | -$1.99M derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | -$1.09M 10-Q · filed 2017-08-21 | -$1.64M derived: sum of 3 quarters · filed 2017-08-21 | ||
| 2016-03-31 | -$544.00K 10-Q · filed 2017-05-15 | -$1.09M derived: sum of 2 quarters · filed 2017-05-15 | |||
| 2015-12-31 | -$551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$971.00K 10-K · filed 2017-03-31 | |||
| 2015-09-30 | -$420.00K 10-Q · filed 2016-11-14 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-05-12 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |